Early intervention for relapse in schizophrenia: Results of a 12-month randomized controlled trial of cognitive behavioural therapy

Psychological Medicine

Volumn 33, Issue 3, 2003, Pages 419-431

  Gumley, Andrew ^a,b   O'Grady, M ^a,b   McNay, L ^a,b   Reilly, J ^a,b   Power, K ^a,b   Norrie, J ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HAZARD ASSESSMENT; HOSPITAL ADMISSION; HUMAN; INDEPENDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METHODOLOGY; NEGATIVE SYNDROME; POSITIVE SYNDROME; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TREATMENT OUTCOME;

COGNITIVE THERAPY; CRISIS INTERVENTION; FEMALE; HUMANS; MALE; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037389036     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291703007323     Document Type: Article

References (63)

1. American Psychiatric Association (1994). The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. American Psychiatric Association: Washington, DC.
2. Atkins, M., Burgess, A., Bottomly, C. & Riccio, M. (1997). Chlorpromazine equivalents: a consensus opinion for both clinical and research applications. Psychiatric Bulletin 21, 224-226.
3. Barrowclough, C. & Tarrier, N. (1990). Social functioning in schizophrenic patients. Social Psychiatry and Psychiatric Epidemiology 25, 125-129.
4. Birchwood, M. (1995). Early intervention in psychotic relapse: cognitive approaches to detection and management. Behaviour Change 12, 2-19.
5. Birchwood, M. & Spencer, E. (2001). Early intervention in psychotic relapse. Clinical Psychology Review 21, 1211-1226.
6. Birchwood, M., Smith, J., Macmillan, F., Hogg, B., Prasad, R., Harvey, C. & Bering, S. (1989). Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers. Psychological Medicine 19, 649-656.
7. Birchwood, M., Smith, J., Cochrane, R., Wetton, C. & Copestake, S. (1990). The Social Functioning Scale: the development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry 157, 853-859.
8. Birchwood, M., Mason, R. & Macmillan, F. (1993). Depression, demoralisation and control over psychotic illness. Psychological Medicine 23, 387-395.
9. Brier, A. & Strauss, J. S. (1983). Self control in psychiatric disorders. Archives of General Psychiatry 40, 1141-1145.
10. Crow, T. J., MacMillan, J. F., Johnson, A. L. & Johnstone, E. C. (1986). The Northwick Park study of first episodes of schizophrenia. III. Short term outcome in trial entrants and trial eligible patients. British Journal of Psychiatry 148, 128-133.
11. Davidson, K. M. (2000). Cognitive Therapy for Personality Disorders. Butterworth-Heinemann, Oxford.
12. De Haan, L., Linszen, D. H. & Gorsira, R. (1998). Early intervention, social functioning and psychotic relapse of patients with recent-onset schizophrenic disorders. International Clinical Psychopharmacology 13, 63-66.
13. Derogatis, L. & Melisaratos, N. (1983). The Brief Symptom Inventory: an introductory report. Psychological Medicine 13, 595-605.
14. Drury, V., Birchwood, M., Cochrane, R. & Macmillan, F. (1996a). Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. British Journal of Psychiatry 169, 593-601.
15. Drury, V., Birchwood, M., Cochrane, R. & Macmillan, F. (1996b). Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry 169, 602-607.
16. Drury, V., Birchwood, M. & Cochrane, R. (2000). Cognitive therapy and recovery from acute psychosis: a controlled trial. 3. Five-year follow-up. British Journal of Psychiatry 177, 8-14.
17. First, M. B., Spitzer, R. L., Gibbon, M. & Williams, J. B. W. (1994). Structured Clinical Intervieiw for DSM-IV Axis I Disorders (SCID). New York State Psychiatric Institute, Biometrics Research: New York.
18. Gaebel, W. & Pietzcker, A. (1985). One year outcome of schizophrenic patients: interaction of chronicity and neuroleptic treatment. Pharmacopsychiatry 18, 235-239.
19. Gaebel, W., Frick, U., Kopcke, W., Linden, M., Muller, P., Muller-Spahn, F., Pietzcker, A. & Tegeler, J. (1993). Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse? British Journal of Psychiatry 163 (Suppl. 21), 8-12.
20. Gumley, A. I. & Power. K. G. (2000). Is targeting cognitive therapy during early relapse in psychosis feasible? Behavioural and Cognitive Psychotherapy 28, 161-174.
21. Gumley, A. I., White, C. A. & Power, K. G. (1999). An interacting cognitive subsystems model of relapse and course of psychosis. Clinical Psychology and Psychotherapy 6, 261-278.
22. Herz, M.I., Lamberti, J.S., Mintz, J., Scott, R., O'Dell, S.P., McCartan, L. & Nix, G. (2000). A programme for relapse prevention in schizophrenia: a controlled study. Archives of General Psychiatry 57, 277-283.
23. Hogarty, G. E., Anderson, C. M., Reiss, D. J., Kornblith, S. J., Greenwald, D., Ulrich, R. F. & Carter, M. (1991). Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. Archives of General Psychiatry, 48, 340-347.
24. Hogarty, G. E., Kornblith, S. J., Greenwald, D., DiBarry, A. L., Cooley, S., Ulrich, R. H., Carter, M. & Flesher, S. (1997a). Three year trials of personal therapy among schizophrenic patients living with or independent of family. I. Description of study and effects on relapse rates. American Journal of Psychiatry 154, 1504-1513.
25. Hogarty, G. E., Greenwald. D., Ulrich, R. H., Kornblith, S. J., DiBarry, A. L., Cooley, S., Carter, M. & Flesher, S. (1997b). Three year trials of personal therapy among schizophrenic patients living with or independent of family. II. Effects on adjustment of patients. American Journal of Psychiatry 154, 1514-1524.
26. Hultman, C. M., Weiselgren, I.-M. & Ohman, A. (1997). Relationships between social support, social coping and life events in the relapse of schizophrenic patients. Scandinavian Journal of Psychology 38, 3-13.
27. Iqbal, Z., Birchwood, M., Chadwick, P. & Trower, P. (2000). Cognitive approach to depression and suicidal thinking in psychosis. 2. Testing the validity of the social ranking model. British Journal of Psychiatry 177, 522-528.
28. Jacobson, N. S. & Truax, P. (1991). Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 59, 12-19.
29. Jolley, A. G., Hirsch, S. R., Morrison, E., McRink, A. & Wilson, L. (1990). A trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years. British Medical Journal 301, 837-842.
30. Jorgensen, P. (1998). Early signs of psychotic relapse in schizophrenia. British Journal of Psychiatry 172, 327-330.
31. Kavanagh, D. (1992). Recent developments in expressed emotion and schizophrenia. British Journal of Psychiatry 37, 51-56.
32. Kay, S., Fizbein, A. & Opler, L. (1987). The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophrenia Bulletin 13, 261-275.
33. Kemp, R., Kirov, B., Everitt, B., Hayward, P. & David, A. (1998). Randomised controlled trial of compliance therapy; 18-month follow-up. British Journal of Psychiatry 172, 413-419.
34. Kuipers, E., Garety, P., Fowler, D., Dunn, G., Bebbington, P., Freeman, D. & Hadley, C. (1997). London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. II: effects of the treatment phase. British Journal of Psychiatry 171, 319-327.
35. Kuipers, E., Fowler, D., Garety, P., Chisolm, D., Freeman, D., Dunn, G., Bebbington, P. & Hadley, C. (1998). London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. III: follow-up and economic evaluation at 18 months. British Journal of Psychiatry 173, 61-68.
36. Lam, D. H. & Wong, G. (1997). Prodromes, coping strategies, insight and social functioning in bipolar affective disorders. Psychological Medicine 27, 1091-1100.
37. Lam, D. H., Bright, J., Jones, S., Hayward, P., Schuck, N., Chisholm, D. & Sham, P. (2000). Cognitive therapy for bipolar illness - a pilot study of relapse prevention. Cognitive Therapy and Research 24, 403-520.
38. Lam, D. H., Wong, G. & Sham, P. (2001). Prodromes, coping strategies and the course of illness in bipolar affective disorder - a naturalistic study. Psychological Medicine 31, 1397-1402.
39. Linszen, D. H., Dingemans, P. M. A. J., Lenior, M. E., Scholte, W. F., De Haan, L. & Goldstein, M. J. (1998). Early detection and intervention in schizophrenia. International Clinical Psychopharmacology, 13, 31-34.
40. McCandless-Glincher, L., McKnight, S., Hamera, E., Smith, B. L., Paterson, K. & Plumlee, A. A. (1986). Use of symptoms by schizophrenics to monitor and regulate their illness. Hospital and Community Psychiatry, 37, 929-933.
41. Marder, S. R., Mintz, J., Van Putten, T., Lebell, M., Wirshing, W. C. & Johnson-Cronk, K. (1991). Early prediction of relapse in schizophrenia: an application of receiver operating characteristic (ROC) methods. Psychopharmacology Bulletin 27, 79-82.
42. Marder, S. R., Wirshing, W. C., Van Putten, T., Mintz, J., McKenzie. J., Johnson-Cronk, K., Lebell, M. & Liberman, R. P. (1994). Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia. Archives of General Psychiatry 51, 280-287.
43. Perry, A., Tarrier, N., Morriss, R., McCarthy, E. & Limb, K. (1999). Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. British Medical Journal 318, 149-153.
44. Pinto, A., La Pia, S., Manella, R., Giorgio, D. & DiSimone, L. (1999). Cognitive behavioural therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services 50, 901-904.
45. Pocock, S. J. (1996). Clinical Trials: A Pragmatic Approach. John Wiley & Sons: Chichester.
46. Resick, P. A. & Schnicke, M. K. (1993). Cognitive Processing Therapy for Rape Victims: A Treatment Manual. Sage: California.
47. Robinson, D., Woerner, M. G., Alver, J., Bilder, R., Goldman, R., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D. & Leiberman, J. (1999). Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 56, 241-247.
48. Rosenberg, M. (1965). Society and the Adolescent Self-Image. Princeton University Press: Princeton, NJ.
49. Scott, J., Garland, A. & Moorhead, S. (2001). A pilot study of cognitive therapy in bipolar disorders. Psychological Medicine 31, 459-467.
50. Sensky, T., Turkington, D., Kingdon, D., Scott, J. L., Scott, J., Siddle, R., O'Carroll, M. & Barnes, T. R. E. (2000). A randomised controlled trial of cognitive behavioural therapy in schizophrenia resistant to medication. Archives of General Psychiatry 57, 165-172.
51. Shepherd, M., Watt, D., Falloon, I. & Smeeton, N. (1989). The natural history of schizophrenia: a five year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychological Medicine. Monograph Supplement 15, page 46. Cambridge University Press: Cambridge.
52. Speigel, G. & Wissler, T. (1987). Using family consultation as a psychiatric aftercare for schizophrenic patients. Hospital and Community Psychiatry 38, 1096-1099.
53. Subotnik, K. L. & Nuechterlein, K. H. (1988). Prodromal signs and symptoms of schizophrenic relapse. Journal of Abnormal Psychology 97, 405-412.
54. Tait, A., McNay, L., Gumley, A. I. & O'Grady, M. (2002). The development and implementation of an idiosyncratic early signs monitoring system. Journal of Mental Health 11, 141-153.
55. Tarrier, N., Barrowclough, C. & Bamrah, J. S. (1991). Prodromal symptoms of relapse in schizophrenia. Social Psychiatry and Psychiatric Epidemiology 26, 157-161.
56. Tarrier, N., Beckett, R., Harwood, S., Baker, A., Yusupoff, L. & Ugarteburu, I. (1993). A trial of two cognitive-behavioural methods of treating drug-residual psychotic symptoms in schizophrenic patients: outcome. British Journal of Psychiatry 162, 524-532.
57. Tarrier, N., Yusupoff, L., Kinney, C., McCarthy, E., Gledhill, A., Haddock, G. & Morris, J. (1998). Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. British Medical Journal 317, 303-307.
58. Tarrier, N., Wittkowsky, A., Kinney, C., McCarthy, E., Morris, J. & Humphreys, L. (1999). Durability of the effects of cognitive-behavioural therapy in the treatment of chronic schizophrenia: 12-month follow-up. British Journal of Psychiatry 174, 500-504.
59. Tarrier, N., Kinney, C., McCarthy, E., Humphreys, L. & Wittkowsky, A. (2000). Two-year follow-up of cognitive-behavioural therapy and supportive counselling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology 68, 917-922.
60. Turkington, D., Kingdon, D., Turner, T. & Insight into Schizophrenia Research Group (2002). Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry 18, 523-527.
61. Vaughn, K., Doyle, M., McConaghy, N., Blaszczynski, A., Fox, A. & Tarrier, N. (1992). The relationship between relatives expressed emotion and schizophrenic relapse: an Australian application. Social Psychiatry and Psychiatric Epidemiology 27, 10-15.
62. Wiersma, D., Nienhuis, F. J., Sloff, C. J. & Giel, R. (1998). Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort. Schizophrenia Bulletin 24, 75-85.
63. Xiang, M., Ran, M. & Li, S. (1994). A controlled evaluation of psychoeducational family intervention in a rural Chinese community. British Journal of Psychiatry 165, 544-548.